Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconVRTXVertex Pharmaceuticals$126.85bn29.97n/a
us flag iconREGNRegeneron Pharmaceuticals$117.19bn29.76n/a
us flag iconMRNAModerna$46.43bnn/an/a
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconIQVIqvia Holdings$40.92bn29.16n/a
us flag iconALNYAlnylam Pharmaceuticals$30.08bnn/an/a
us flag iconICLRIcon$27.26bn36.46n/a
us flag iconBNTXBioNTech SE$20.32bn156.51n/a
us flag iconASNDAscendis Pharma A/S$15.75bnn/an/a
us flag iconNBIXNeurocrine Biosciences$14.66bn39.62n/a
us flag iconUTHRUnited Therapeutics$14.60bn15.54n/a
us flag iconSRPTSarepta Therapeutics$13.76bnn/an/a
us flag iconMEDPMedpace Holdings$13.05bn42.93n/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconINSMInsmed$12.39bnn/an/a
us flag iconTECHBIO-TECHNE$11.89bn56.180.42%
us flag iconCRLCharles River Laboratories International$11.24bn23.37n/a
us flag iconLEGNLegend Biotech$10.71bnn/an/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconQGENQiagen NV$9.30bn25.41n/a